We are live on
!
Find out more
DC
DeDora Capital Portfolio holdings
AUM
$460M
1-Year Est. Return
25.48%
This Fund
S&P 500
This Quarter
Est. Return
+3.93%
1 Year Est. Return
+25.48%
3 Year Est. Return
+81.75%
5 Year Est. Return
+94.57%
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$9.51M
(+7.2%)
Cap. Flow
+$4.6M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
53.52%
Holding
92
New
7
Increased
49
Reduced
24
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$878K |
| 2 |
Thermo Fisher Scientific
TMO
|
+$810K |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611K |
| 4 |
Accenture
ACN
|
+$410K |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$401K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$491K |
| 2 |
CME Group
CME
|
+$421K |
| 3 |
Enbridge
ENB
|
+$340K |
| 4 |
Invesco California AMT-Free Municipal Bond ETF
PWZ
|
+$289K |
| 5 |
Lowe's Companies
LOW
|
+$213K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.46% |
| 2 | Healthcare | 8.33% |
| 3 | Communication Services | 7.58% |
| 4 | Consumer Discretionary | 6.4% |
| 5 | Financials | 4.45% |
Similar funds
MCB
FCMV
PC
PIN
AA
GLAM
PRCP
UAM
DeDora Capital's Q2 2019 Portfolio in Review
As of Q2 2019, DeDora Capital held 92 positions worth $142M, up 7.2% from $133M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
DeDora Capital deployed $4.6M of net new capital in Q2 2019, opening 7 new positions and adding to 49 existing holdings. Its largest new stake was Thermo Fisher Scientific: 2,940 shares worth $863K.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was AbbVie, an estimated $491K trimmed.
- DeDora Capital's largest Q2 2019 buy was Thermo Fisher Scientific: 2,940 shares worth $863K.
- DeDora Capital added most to Invesco S&P 500 Equal Weight ETF in Q2 2019, an estimated $878K increase.
- DeDora Capital's biggest Q2 2019 reduction was AbbVie, cutting an estimated $491K.
- DeDora Capital fully exited Enbridge in Q2 2019, selling an estimated $340K.
- DeDora Capital's ten largest holdings make up 54% of its $142M portfolio in Q2 2019.
- DeDora Capital opened 7 new positions and closed 3 in Q2 2019.
- DeDora Capital's portfolio value rose 7.2% quarter-over-quarter to $142M.
Based on DeDora Capital's 13F filing for Q2 2019, filed 24 Jul 2019.